Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study

BACKGROUND: The efficacy of Mycophenolate mofetil (MMF) plus interferon beta-1a (IFNB-1a) in treatment of relapsing-remitting multiple sclerosis (RRMS) was evaluated. METHODS: This was a pilot study with randomized, double-blinded, placebo-controlled design. Patients with RRMS and Expanded Disabilit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Etemadifar, Masoud, Kazemi, Mojtaba, Chitsaz, Ahmad, Hekmatnia, Ali, Tayari, Nazila, Ghazavi, Amirhossein, Maghzi, Amir Hadi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Medknow Publications & Media Pvt Ltd 2011
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3063426/
https://ncbi.nlm.nih.gov/pubmed/21448376
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller